Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF and Growth Hormone in Decompensated Liver Cirrhosis
NCT02451033Phase 3Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- May 2015
- Primary completion
- Jun 2016
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of granulocyte colony-stimulating factor and somatropin in Liver cirrhosis (LC) (3 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Transplant free survival at 1 year. Started May 2015; status: completed.
02
Drugs
granulocyte colony-stimulating factorsomatropin
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT02451033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02451033.